Cancer Biology Research in New York
Cancer Biology Research (93.396) awarded $712 million to recipients in New York in 426 grants from fiscal 2021 to 2025, 17% of the program's national total. The Trustees of Columbia University in the City of New York received the most, $151 million.
- Awarded in New York$712 million
- Awards426
- Share of the program17%
- Rank among states1st of 50
- National total$4.3 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 215 | $117 million |
| FY 2022 | 239 | $135 million |
| FY 2023 | 257 | $144 million |
| FY 2024 | 263 | $148 million |
| FY 2025 | 253 | $167 million |
Recipients in New York
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Trustees of Columbia University in the City of New York | Colleges and universities | 70 | $151 million |
| Sloan-Kettering Institute for Cancer Research | Nonprofits | 66 | $136 million |
| Weill Medical College of Cornell University | Colleges and universities | 53 | $86.8 million |
| Icahn School of Medicine at Mount Sinai | Colleges and universities | 41 | $67.9 million |
| New York University | Colleges and universities | 41 | $67.0 million |
| Cold Spring Harbor Laboratory | Other | 26 | $43.2 million |
| Albert Einstein College of Medicine, Inc. | Colleges and universities | 23 | $38.6 million |
| Health Research, Inc. | Nonprofits | 25 | $32.5 million |
| The Research Foundation for the State University of New York | Other | 12 | $14.5 million |
| The Rockefeller University | Colleges and universities | 9 | $14.5 million |
Open opportunities under this program
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much Cancer Biology Research money goes to New York?
$712 million from fiscal 2021 to 2025, across 426 awards. New York ranks 1st of 50 states and territories for this program.
Who receives Cancer Biology Research money in New York?
The largest recipient is The Trustees of Columbia University in the City of New York, with $151 million in 70 awards. Next are Sloan-Kettering Institute for Cancer Research and Weill Medical College of Cornell University.
Can organizations in New York apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Biology Research in other states
Other large programs in New York
- Grants to States for Medicaid
- 1332 State Innovation Waivers
- Federal Transit Formula Grants
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Highway Planning and Construction
- National School Lunch Program
- Children's Health Insurance Program
- Public Housing Operating Fund